Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accessing, ACIP, API, biomarker, CDC, competitor, conduct, curatively, damage, distinct, exceeded, formation, gene, germline, GmbH, growing, Hurricane, inability, infrastructure, innate, island, Italian, Italy, landfall, larger, learned, Maria, marketplace, Milan, nonfinancial, open, plant, point, power, preferred, prejudgment, Prosecution, Puerto, reliant, replenish, resumed, retinoic, Rico, Rigontec, shutdown, slightly, transparency, unique, unrespectable, water, withdrawn
Removed:
advance, Amneal, antibacterial, Apotex, aprepitant, audit, automatically, bezlotoxumab, biologic, Biopharma, Cabilly, CDI, Clostridium, cover, creation, declaratory, delivery, difficile, Emend, event, excluding, finalization, fluralaner, Genentech, glargine, heard, Hope, impaired, indirectly, insulin, Inter, IPR, manufacture, nausea, PDL, platform, projected, proposed, recurrence, Samsung, Switzerland, taxing, technology, uncertain, USA, USPTO, vomiting, whichever, Zinplava
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view